ES2418459R1 - Relacionando agregacion proteica con supervivencia de levadura - Google Patents

Relacionando agregacion proteica con supervivencia de levadura

Info

Publication number
ES2418459R1
ES2418459R1 ES201190025A ES201190025A ES2418459R1 ES 2418459 R1 ES2418459 R1 ES 2418459R1 ES 201190025 A ES201190025 A ES 201190025A ES 201190025 A ES201190025 A ES 201190025A ES 2418459 R1 ES2418459 R1 ES 2418459R1
Authority
ES
Spain
Prior art keywords
aggregation
enzyme
protein
cell
survival
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201190025A
Other languages
English (en)
Other versions
ES2418459A2 (es
ES2418459B1 (es
Inventor
Zamora Salvador Ventura
Puigvert Francesc Xavier Aviles
Fernandez Montserrat Morell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitat Autonoma de Barcelona UAB
Original Assignee
Universitat Autonoma de Barcelona UAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitat Autonoma de Barcelona UAB filed Critical Universitat Autonoma de Barcelona UAB
Publication of ES2418459A2 publication Critical patent/ES2418459A2/es
Publication of ES2418459R1 publication Critical patent/ES2418459R1/es
Application granted granted Critical
Publication of ES2418459B1 publication Critical patent/ES2418459B1/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4709—Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/906—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
    • G01N2333/9065—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on CH-NH groups of donors (1.5)
    • G01N2333/90655—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1) in general
    • G01N2333/90661—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1) in general with a definite EC number (1.5.1.-)
    • G01N2333/90666—Dihydrofolate reductase [DHFR] (1.5.1.3)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Abstract

Relacionando agregación proteica con supervivencia de levadura. La invención se refiere a métodos para la identificación de compuestos capaces de prevenir la agregación de polipéptidos propensos a la agregación basados en el uso de proteínas de fusión. Las proteínas de fusión comprenden la proteína de interés y una enzima que es capaz de metabolizar un agente tóxico para la célula. Si el compuesto candidato previene la agregación de la proteína de fusión, el enzima se mantiene soluble y en forma activa, evitando así el efecto tóxico en la célula e incrementando la viabilidad celular respecto a la de células no expuestas al compuesto candidato. La invención también proporciona diferentes polipéptidos que contienen un polipéptido con tendencia a agregar y una enzima, y describe la utilización de los mismos.
ES201190025A 2008-10-09 2009-10-09 Relacionando agregación proteica con supervivencia de levadura Active ES2418459B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08017708 2008-10-09
PCT/EP2009/063213 WO2010040842A1 (en) 2008-10-09 2009-10-09 Linking protein aggregation and yeast survival

Publications (3)

Publication Number Publication Date
ES2418459A2 ES2418459A2 (es) 2013-08-13
ES2418459R1 true ES2418459R1 (es) 2013-10-11
ES2418459B1 ES2418459B1 (es) 2014-08-12

Family

ID=41478848

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201190025A Active ES2418459B1 (es) 2008-10-09 2009-10-09 Relacionando agregación proteica con supervivencia de levadura

Country Status (2)

Country Link
ES (1) ES2418459B1 (es)
WO (1) WO2010040842A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015521863A (ja) * 2012-07-13 2015-08-03 エル． ホルツマン，ジョーダン アルツハイマー病の治療のための治療薬剤をスクリーニングするための細胞モデルと動物モデル
CN103525858B (zh) * 2013-09-29 2015-12-09 深圳大学 高通量筛选抗亨廷顿疾病活性物质的植物细胞模型的建立方法及其应用
GB201414038D0 (en) * 2014-08-07 2014-09-24 Univ Sussex The Alzheimer's disease
CN113552102B (zh) * 2021-07-16 2022-05-17 上海交通大学 一种基于荧光相关光谱检测有机溶剂诱导蛋白聚集的药物筛选方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002065136A2 (en) * 2001-02-15 2002-08-22 University Of Chicago Yeast screens for agents affecting protein folding
WO2003044051A1 (en) * 2001-11-20 2003-05-30 Atgen Co., Ltd. Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
US6982146B1 (en) * 1999-08-30 2006-01-03 The United States Of America As Represented By The Department Of Health And Human Services High speed parallel molecular nucleic acid sequencing
US20070212679A1 (en) * 2005-12-12 2007-09-13 Elan Pharmaceuticals, Inc. Assay for parkinson's disease therapeutics and enzymatically active parkin preparations useful therein
WO2007103788A2 (en) * 2006-03-02 2007-09-13 The Board Of Trustees Of The University Of Illinois Yeast reporter system based on fusion proteins of sup35p

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6982146B1 (en) * 1999-08-30 2006-01-03 The United States Of America As Represented By The Department Of Health And Human Services High speed parallel molecular nucleic acid sequencing
WO2002065136A2 (en) * 2001-02-15 2002-08-22 University Of Chicago Yeast screens for agents affecting protein folding
WO2003044051A1 (en) * 2001-11-20 2003-05-30 Atgen Co., Ltd. Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
US20070212679A1 (en) * 2005-12-12 2007-09-13 Elan Pharmaceuticals, Inc. Assay for parkinson's disease therapeutics and enzymatically active parkin preparations useful therein
WO2007103788A2 (en) * 2006-03-02 2007-09-13 The Board Of Trustees Of The University Of Illinois Yeast reporter system based on fusion proteins of sup35p

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANANDATHEERTHAVARADA H K et al. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells.THE JOURNAL OF CELL BIOLOGY : JCB, 20030414 The Rockefeller University Press, US 14/04/2003 VOL: 161 No: 1 Pags: 41 - 54 ISSN 0021-9525 Doi: doi:10.1083/jcb.200207030. Página 45, columna izquierda, párrafo tercero, y figura 4. *
BAGRIANTSEV SVIATOSLAV; LIEBMAN SUSAN. Modulation of A beta(42) low-n oligomerization using a novel yeast reporter system. BMC BIOLOGY, vol.4, no.1 26.09.2006, página 32. Resumen. *
DYSON MICHAEL R et al. Identification of soluble protein fragments by gene fragmentation and genetic selection.Nucleic Acids Research, 20080101 Information Retrieval Ltd 01/01/2008 VOL: 36 No: 9 Pags: e51 - 12pages ISSN 0305-1048 Doi: doi:10.1093/nar/gkn151.Página 2, columna izquierda, párrafos 2 y 3; página 3, columna derecha, párrafo 3 y página 4, columna izquierda. *

Also Published As

Publication number Publication date
ES2418459A2 (es) 2013-08-13
WO2010040842A9 (en) 2010-06-03
ES2418459B1 (es) 2014-08-12
WO2010040842A1 (en) 2010-04-15

Similar Documents

Publication Publication Date Title
ES2524723T3 (es) Fructosil peptidil oxidasa y un sensor para analizar una proteína glucosilada
ES2507520T3 (es) Aislamiento y/o identificación de células madre con potencial de diferenciación adipocitario, condrocitario y pancreático
HN2008001104A (es) Compuestos para anticuerpos de dickpf-1 y70-4
AR090822A1 (es) Composiciones de cultivo de celulas y metodos para la produccion de polipeptidos
CL2007000664A1 (es) Procedimiento para obtener una composicion termoestable de proteina seca y alcohol liquido anhidro premezclando la fraccion liquida anhidra, separadamente premezclar la fraccion seca y mezclar obteniendo una masa homogenea manteniendo la temperatura de la mezcla por debajo de la temperatura de endurecimiento de la composicion.
BRPI0919034A8 (pt) Métodos para produzir uma proteína e um anticorpo, meio líquido aquoso para cultura, e, vaso
BR112012018163A2 (pt) métodos e composições para exibição de um polipeptídeo sobre a superfície de uma célula de levredura
AR056748A1 (es) Solucion de cloruro de sodio para reconstitucion o dilucion de farmaco
PE20090731A1 (es) Metodos de produccion de proteinas basados en medios de cultivos celulares que comprenden compuestos anti-senescencia
AR070716A1 (es) Metodos para modificar el punto isoelectrico de anticuerpos mediante la sustitucion de aminoacidos en la region de determinacion de la complementariedad (cdr)
WO2011031497A3 (en) Quantitative fluorescent protein standards
ES2479542T1 (es) Métodos y composiciones para su uso en terapias celulares
ES2418459R1 (es) Relacionando agregacion proteica con supervivencia de levadura
WO2006017751A3 (en) Methods for the detection of molecular interactions within cells
WO2009023331A3 (en) Antibodies and improved test sample handling methods for use in assays for myeloperoxidase
ES2564186T3 (es) Uso para fines de cribado de activos anti-envejecimiento de formas solubles de la proteína del tipo desmogleína I
WO2006004936A3 (en) Analysis of intracellular modifications
MX2022005093A (es) Métodos de secuenciación de proteína de una sola célula y ácido nucleico.
WO2007005611A3 (en) Progenitor cells and uses thereof
GB201113814D0 (en) Materials and methods for determining sensitivity potential of compounds
ES2571929T3 (es) Procedimiento para determinar la cantidad de CD36 circulante
ATE461999T1 (de) Detektion von verkürzungsmutationen durch massenspektrometrie
WO2021118727A3 (en) Fluorogenic amino acids
WO2008052737A3 (en) Immunochemically equivalent hiv drug analogs
WO2008002656A3 (en) Methods and materials for in vitro analysis and/or use of membrane-associated proteins, portions thereof or variants thereof

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2418459

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20140812